CME
stock Financial Services Financial Data & Stock ExchangesOverall Mixed · 57%
- Fundamentals Strong
- Trajectory Steady
- Leadership Normal
A read across fundamentals, recent price & growth trajectory, and leadership stability. For fun and reading at a glance, not investment advice.
What the indicators say
Mixed 1 of 5 trend signals bullishRSI 25 — oversold: selling looks stretched and may be due for a bounce.
A mechanical reading of the chart’s indicators — not investment advice.
Key statsas of Jun 3
- Open
- $252.64
- +0.84%
- Close
- $252.64
- +0.84%
- Current
- $252.64
- Prev close
- $250.53
- Today
- 4.64M
- 3-mo avg
- 2.56M
Earningscalendar synced from Yahoo 57d ago
- Most recent
- Apr 2290 days ago
- Next expected
- Jul 22in 1 day
Recent earnings dates
- Apr 22 90 days ago
- Feb 4 167 days ago
- Oct 22, 2025 272 days ago
- Jul 23, 2025 363 days ago
Past earnings dates come from CME’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.
Fundamentalssynced from SEC 51d ago
Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), CME’s fundamentals read as strong overall.
At 21.6x, the price is a reasonable multiple of the company's annual profit.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 2.0% yield is modest: a small income on top of whatever the share price does.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 62.5% margin is strong; the company keeps a healthy slice of every revenue dollar.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 14.2% return on equity is respectable, in the normal range.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 2.1% return on assets is reasonable for a company of this kind.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 5.91, the company leans heavily on borrowing, which adds risk if results weaken.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 1.03, short-term assets cover short-term bills with a little room to spare.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 6.4% from the prior year: steady, modest expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income grew 15.5% from the prior year: strong profit expansion.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financialssynced from SEC 51d ago
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $4.7B | $5.0B | $5.6B | $6.1B | $6.5B |
| Net income | $2.6B | $2.7B | $3.2B | $3.5B | $4.1B |
| Diluted EPS | $7.29 | $7.40 | $8.86 | $9.67 | $11.16 |
| Dividend / share | $5.90 | $8.50 | $9.65 | $10.40 | $5.00 |
| Total assets | $196.8B | $174.2B | $129.7B | $137.4B | $198.4B |
| Total liabilities | $169.4B | $147.3B | $103.0B | $111.0B | $169.7B |
| Shareholder equity | $27.4B | $26.9B | $26.7B | $26.5B | $28.7B |
| Q2-2024 | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.6B | $1.5B | $1.6B | $1.7B | $1.5B | $1.6B | $1.9B |
| Net income | $883.2M | $912.8M | $874.6M | $956.2M | $1.0B | $908.0M | $1.2B | $1.2B |
| Diluted EPS | $2.42 | $2.50 | $2.40 | $2.62 | $2.81 | $2.49 | $3.24 | $3.18 |
| Dividend / share | $1.15 | $1.15 | $6.95 | $1.25 | $1.25 | $1.25 | $1.25 | $7.45 |
Leadershipsynced from SEC 57d ago
- Duffy Terrence A Chairman and CEO · Director
- Fitzpatrick Lynne President and CFO
- Sprague Suzanne COO & Global Head of Clearing
- Cutinho Sunil Chief Information Officer
- Marcus Jonathan L Sr MD General Counsel
- Mccourt Timothy Francis Sr MD Global Head Equity & FX
- Piell Hilda Harris Sr MD & Chief HR Officer
- Sammann Derek Sr MD Gl Hd Commodities Mkts
- Tobin Jack J MD Chief Accounting Officer
- Vroman Ken Chief Transformation Officer
- Winkler Julie Sr MD Chief Commercial Officer
- Cook Elizabeth A Director
- Durkin Bryan T Director
- Ford Harold Eugene Jr. Director
- Gepsman Martin J Director
- Shepard William R Director
- Suskind Dennis Director
Officers and board are drawn from CME’s recent SEC ownership filings (Forms 3, 4 and 5).
Recent leadership changes
Notable recent eventspast year
- Jun 1 New 6-month low (-21% off peak)
- Jun 1 −5.8% one-day move
- Sep 11, 2025 Officer or director change reported in an 8-K
Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.
Dividendssynced from Yahoo 52d ago
- 2025 total
- $5.00
- 2026 so far
- $7.451 payment
- 2026 projected
- $29.80+496.0% vs 2025
Projection scales CME’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.
Payment history
- Mar 10 $7.45
- Dec 12, 2025 $1.25
- Sep 9, 2025 $1.25
- Jun 9, 2025 $1.25
- Mar 7, 2025 $1.25
- Dec 27, 2024 $5.80
- Dec 9, 2024 $1.15
- Sep 9, 2024 $1.15
- Jun 7, 2024 $1.15
- Mar 7, 2024 $1.15
- Dec 27, 2023 $5.25
- Dec 7, 2023 $1.10
- Sep 7, 2023 $1.10
- Jun 8, 2023 $1.10
- Mar 9, 2023 $1.10
- Dec 27, 2022 $4.50
- Dec 8, 2022 $1.00
- Sep 8, 2022 $1.00
- Jun 9, 2022 $1.00
- Mar 9, 2022 $1.00
- Dec 27, 2021 $3.25
- Dec 9, 2021 $0.90
- Sep 9, 2021 $0.90
- Jun 9, 2021 $0.90
Recent SEC filingssynced from SEC 51d ago
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- DEF 14A Proxy statement
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report